Browsing by Author "Kumar, D. Mohan"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Comparative-study-of-percutaneous-nephrolithotomy-in-supine-versus-prone-position
    (Indian Society for Health and Advanced Research, 2023-03) Babu, N. Dhinakar; Kumar, D. Mohan
    Prone positioning in percutaneous nephrolithotomy is more and more being replaced by supine positioning now a days for its various benefits. This is a prospective study which does Comparative study on percutaneous nephrolithotomy in supine versus prone position and their various outcomes were analysed. There were totally 100 patients included in the study with 50 patients each group (supine versus prone). 57 were male and 43 female patients. Age ranging from 18 to 70 years. Right side stones were 58 and left side was 42. Age, gender and side of stones were similar between two groups. Stone burden were 2.6cm and 2.9cm for supine and prone group respectively. But average operating time were 63.5 minutes ( 35 to 120 minutes) for supine group versus 80 minutes ( 45 to 160 minutes) for prone group. fluoroscopy time was 18.9 minutes for supine group versus 29.4 minutes for prone group. Clearance rate in our study were pretty good in both groups around 90% in both groups (90% vs 88%). five had complications in form of sepsis and bleeding requiring blood transfusion in both groups. Five in supine group and six in prone group required second procedures. Thus Supine percutaneous nephrolithotomy group had significant advantage in terms of less operative duration and less fluoroscopy time than prone percutaneous nephrolithotomy . The stone clearance and complication rates were similar in both the groups.
  • No Thumbnail Available
    Item
    A Pharmacological and Therapeutic Plant Review of Bhallataka (Semecarpus Anacardium) in Classical and Modern Medicine
    (Mahadev Publications, 2025-05) Kumar, D. Mohan; Durga, Ch. Sri
    Bhallataka (Semecarpus anacardium Linn.), commonly known as the marking nut tree, is a widely utilized medicinal plant in Ayurveda, recognized for its diverse pharmacological activities. Classical Ayurvedic texts such as Charaka Samhita, Sushruta Samhita, Ashtanga Hridaya, and various Nighantus extensively document its properties, formulations, and therapeutic indications. It is classified under Upavisha (semi-poisonous drugs), requiring meticulous purification (Shodhana) before internal use. Various parts of the plant-particularly the seed, kernel (Majja), fruit, and oil-exhibit actions such as Deepana, Pachana, Krimighna, Shukrala, Rasayana, and Kaphavatahara. These properties make Bhallataka valuable in treating conditions like Kushtha (skin disorders), Arsha (piles), Grahani (IBS), Gulma (abdominal masses), Pandu (anaemia), and Vatarakta (gout). Modern pharmacological research has corroborated many classical claims, demonstrating its anti-inflammatory, immunomodulatory, antimicrobial, antioxidant, and anticancer effects. Phytochemical investigations reveal bioactive constituents like bhilawanol, semecarpol, anacardol, and biflavonoids responsible for its therapeutic efficacy. Despite its efficacy, improper handling may cause severe toxic reactions; hence, traditional antidotes and dietary guidelines (Pathya-Apathya) are crucial during administration. This review compiles comprehensive information from classical and contemporary sources to present a holistic understanding of Bhallataka-from its botanical description, purification techniques, therapeutic actions, and formulations to modern evidence-based validations highlighting its integrative significance in traditional and modern medicine.